Fullcircle Wealth LLC Buys New Position in CME Group Inc. (NASDAQ:CME)

Fullcircle Wealth LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 3rd quarter, HoldingsChannel reports. The firm bought 1,407 shares of the financial services provider’s stock, valued at approximately $321,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of CME. Chicago Partners Investment Group LLC boosted its position in CME Group by 1.9% during the 3rd quarter. Chicago Partners Investment Group LLC now owns 26,675 shares of the financial services provider’s stock valued at $6,059,000 after purchasing an additional 497 shares during the period. Keystone Financial Planning Inc. raised its position in shares of CME Group by 1.6% during the third quarter. Keystone Financial Planning Inc. now owns 35,235 shares of the financial services provider’s stock worth $7,775,000 after purchasing an additional 559 shares during the period. Hartford Financial Management Inc. raised its position in CME Group by 8.5% during the third quarter. Hartford Financial Management Inc. now owns 8,752 shares of the financial services provider’s stock valued at $1,931,000 after buying an additional 688 shares during the period. Manitou Investment Management Ltd. grew its stake in CME Group by 7.1% in the third quarter. Manitou Investment Management Ltd. now owns 3,060 shares of the financial services provider’s stock valued at $675,000 after purchasing an additional 203 shares in the last quarter. Finally, HM Payson & Co. grew its stake in CME Group by 33.6% in the third quarter. HM Payson & Co. now owns 962 shares of the financial services provider’s stock valued at $212,000 after purchasing an additional 242 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of the company’s stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider Sunil Cutinho sold 4,500 shares of the stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now directly owns 27,053 shares of the company’s stock, valued at $6,131,291.92. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 1,374 shares of the stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $227.12, for a total transaction of $312,062.88. Following the completion of the transaction, the insider now directly owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 15,221 shares of company stock worth $3,351,895. Corporate insiders own 0.30% of the company’s stock.

CME Group Stock Down 0.8 %

Shares of CME traded down $1.75 during trading hours on Friday, hitting $223.61. The stock had a trading volume of 1,318,587 shares, compared to its average volume of 1,917,520. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02. The firm has a 50 day simple moving average of $220.69 and a 200-day simple moving average of $209.46. The firm has a market capitalization of $80.52 billion, a P/E ratio of 23.51, a price-to-earnings-growth ratio of 5.72 and a beta of 0.55. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter in the previous year, the business earned $2.25 EPS. The company’s quarterly revenue was up 18.4% on a year-over-year basis. Sell-side analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.06%. CME Group’s dividend payout ratio is 48.37%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on CME. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research note on Tuesday, October 8th. Morgan Stanley increased their target price on CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a report on Thursday, October 17th. TD Cowen started coverage on CME Group in a report on Thursday, September 26th. They set a “hold” rating and a $221.00 price target for the company. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Finally, Bank of America raised their price target on CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a research report on Thursday, October 3rd. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. According to MarketBeat, CME Group currently has an average rating of “Hold” and a consensus target price of $222.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.